All In Biotech

Drug Trial Radar · NCT05772676

The Effect of Aprepitant Reducing Postoperative Nausea and Vomiting

The Effect of Aprepitant Reducing Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Gastric Sleeve Surgery

Last checked: Nov 20, 2026Latest source record: Mar 16, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 400 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

400

Actual

Start

Dec 1, 2022

Primary completion

Jan 1, 2023

Study completion Apr 1, 2023

Sponsor

Lead sponsor
Hospital General TlahuacGovernment (non-federal)
Sponsor type
Government (non-federal)
First posted
Mar 16, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the efficacy of Aprepitant + standard antiemetic regimen in reducing postoperative nausea and vomiting after laparoscopic gastric sleeve versus placebo + standard antiemetic regimen

Conditions

  • Obesity
  • Nausea and Vomiting, Postoperative

Interventions

  • AprepitantDrug

    80 or 125 mg tablet + standard antiemetic regimen, once two hours before surgery

  • PlaceboOther

    Placebo + standard antiemetic regimen, once two hours before surgery

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Patient's postoperative nausea and vomiting evaluation at 0 hrs (Rhodes index)Time frame: 0 postoperative hours
  2. Patient's postoperative nausea and vomiting evaluation at 6 hrs (Rhodes index)Time frame: 6 postoperative hours
  3. Patient's postoperative nausea and vomiting evaluation at 12 hrs (Rhodes index)Time frame: 12 postoperative hours
  4. Patient's postoperative nausea and vomiting evaluation at 24 hrs (Rhodes index)Time frame: 24 postoperative hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Hospital General Tlahuac

    Mexico City, Mexico

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.